Keywords: Johnson & Johnson, Ortho-McNeil Jansse, Metabolex, Type 2 diabtes, License

J&J’s Ortho-McNeil unit in another diabetes drug accord, this one with Metabolex

Article | 23 June 2010

Print This

USA-based Metabolex revealed yesterday that it has entered into a global development and license agreement with health care giant Johnson & ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in